SStibbe advises leading pharmaceutical company

BE Law

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients and for combination products that are registered based on a well-established use.

The strategy we developed for the client consists of mixing the various types of product registration to influence pricing/reimbursement. It is essential for our client to differentiate its products from those of its competitors so that it could mitigate the impact of price cuts imposed by the authorities.